Daré Bioscience, Inc. (DARE) Social Stream



Daré Bioscience, Inc. (DARE): $0.47

0.01 (-2.49%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add DARE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#123 of 363

in industry

DARE BIOSCIENCE INC (DARE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering DARE BIOSCIENCE INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-08 5 $11 $3 $5.4 $0.309 1647.57%
2022-01-19 6 $11 $3 $5.5 $0.309 1679.94%
2022-04-01 5 $17 $3 $7 $0.309 2165.37%
2022-05-13 5 $17 $3 $7.2 $0.309 2230.1%
2022-08-15 4 $6 $3 $4.8 $0.309 1453.4%
2022-11-14 3 $6 $3 $4.5 $0.309 1356.31%
2022-12-13 4 $7 $3 $4.75 $0.309 1437.22%
2023-01-06 4 $7 $3 $4.8 $0.309 1453.4%
2023-04-04 5 $8 $3 $5.333 $0.309 1625.89%
2023-06-05 5 $8 $3 $5.6 $0.309 1712.3%
2023-08-11 3 $8 $3 $6 $0.309 1841.75%
2023-09-05 3 $7 $3 $5 $0.309 1518.12%
2023-10-20 4 $7 $2 $4 $0.309 1194.5%
2023-11-10 4 $6 $2 $3.75 $0.309 1113.59%

The Trend in the Analyst Price Target


Over the past 34 months, DARE's average price target has gone down $1.45.

Over the past 44 weeks, DARE's average upside potential has been 559.1%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-14 5 8 3 5.333 1.140 367.81%
2023-04-04 5 8 3 5.333 1.040 412.79%
2023-08-11 3 8 3 5.750 0.758 658.58%
2023-09-05 4 7 2 4.666 0.660 606.97%
2023-10-20 4 7 2 4.000 0.464 762.07%

DARE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


DARE's average broker recommendation rating improved by 1 over the prior 34 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DARE as an investment opportunity.

  • DARE BIOSCIENCE INC's upside potential (average analyst target price relative to current price) is greater than 2261.76% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, DARE BIOSCIENCE INC's average analyst price target is higher than 100.15% of them.
  • In the context of stocks in the micro market cap category, DARE BIOSCIENCE INC's variance in analysts' estimates is lower than -1916.6% of them.
  • In terms of how DARE BIOSCIENCE INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 446.13% of that group.

Stocks similar to DARE BIOSCIENCE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AGRX, PHIO, and ORGS.

Is DARE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!